1. China Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
Anhui Huang Shan Capsule Co., Ltd. Class A

Anhui Huang Shan Capsule Co., Ltd. Class A

SSZSE:002817
6.32
CNY
+0.12
(+1.94%)
0.21EPS
27.69P/E
1.75BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.2
1.22
1.13
1.19
0.96
0.97
1.11
1.06
1.27
1.41
1.57
1.54
1.56
1.46
Basic EPS, GAAP
0.21
0.23
0.24
0.22
0.16
0.12
0.13
0.15
0.19
0.2
0.22
0.16
0.22
0.21
Free Cash Flow per Basic Share
-0.09
0.06
0.08
0.07
0.08
-0.02
0.09
-0.1
0.03
0.16
0.32
0.16
0.27
- -
Dividend per Share
0.04
0.05
0.05
0.05
0.04
0.03
0.03
0.03
0.04
0.07
0.06
0.08
0.1
0.07
Book Value per Share
1.06
1.24
1.44
2.11
2.23
2.32
2.42
2.55
2.71
2.85
3.01
3.06
3.21
3.26
Tangible Book Value per Share
0.99
1.17
1.37
2.05
2.17
2.26
2.37
2.5
2.65
2.79
2.95
3
3.15
3.2
Basic Weighted Avg Shares
224
223
226
237
297
303
294
302
299
304
295
308
295
297
Sales/Revenue/Turnover
269
273
254
283
286
295
326
319
380
428
463
473
460
432
Operating Margin (%)
20.04
21.28
24
20.58
15.57
10.94
10.3
12.93
13.94
12.07
13.11
10.42
14.26
14.63
Depreciation Expense
10
10
10
17
24
25
29
29
33
43
46
46
47
- -
Net Income, GAAP
48
52
55
52
46
36
39
45
57
61
65
49
65
63
Effective Tax Rate (%)
13.88
13.36
13.75
14.48
13.84
13.67
14.95
12.06
10.17
- -
9.49
15.91
12.53
13.28
Profit Margin (%)
17.84
18.93
21.63
18.45
16.23
12.2
12.02
14.17
14.97
14.21
14.02
10.4
14.11
14.54
Working Capital
86
98
109
393
430
445
478
442
494
471
347
439
269
322
LT Debt
- -
10
10
- -
- -
1
- -
14
72
- -
10
- -
- -
- -
Total Equity
237
279
324
631
666
697
726
765
810
854
901
918
962
975
Return on Invested Capital (%)
18.88
17.96
16.77
10.24
6.88
4.99
5.16
5.96
6.69
- -
7.36
5.42
6.94
6.42
Return on Capital (%)
20.46
19.28
17.75
10.97
7.27
5.64
5.93
6.25
7.01
- -
7.31
5.35
6.9
6.67
Return on Common Equity (%)
22.11
20.08
18.21
10.95
7.16
5.29
5.52
6.09
7.24
7.32
7.4
5.42
6.93
6.57

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
299
299
299
Market Capitalization
2,273
2,411
1,753

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
400
377
456
Cash, Cash Equivalents & STI
155
109
231
Accounts Receivable, Net
127
120
120
Inventories
76
72
74
Total Current Liabilities
131
122
134
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.8%
4.69%
4.77%
Free Cash Flow
-52.14%
70.1%
62.25%
Net Income, GAAP
3.31%
9.43%
31.94%
Sales/Revenue/Turnover
6.35%
7.85%
-2.76%
Total Cash Common Dividend
14.22%
32.41%
14.12%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
118
117
111
127
473
2025
119
125
- -
116
460
2026
96
95
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.05
0.04
0.03
0.16
2025
0.06
0.06
- -
0.05
0.22
2026
0.06
0.04
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.09
- -
- -
0.08
2025
0.03
0.04
- -
0.03
0.1
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Song Lin Ye
Full Time Employees
639
Sector
Process industries
Industry
Chemicals: major diversified
Address
No. 7 Huangjia Avenue Xuancheng AN China 242600
IPO Date
Oct 25, 2016
Website
hsjn.com
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
AARTI Industries Ltd (NSE:AARTIIND)
Aether Industries Ltd. (NSE:AETHER)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Anhui Huangshan Capsule Co., Ltd. is a China-based pharmaceutical auxiliary manufacturer specializing in the research, development, production, and sales of hollow capsules. Founded in 1989 and headquartered in Huangshan, Anhui Province, the company operates a large-scale manufacturing facility equipped with 72 production lines capable of producing over 30 billion capsules annually. Its core product offerings include gelatin hollow capsules, enteric gelatin hollow capsules, hypromellose (HPMC) hollow capsules, and Prulan polysaccharide hollow capsules. These products serve pharmaceutical and health industries, catering to domestic and international markets. Anhui Huangshan Capsule has established extensive R&D platforms, including a provincial-level enterprise technology center and a post-doctoral research station, emphasizing continuous innovation and collaboration with prominent research institutes and universities across China. Recent major developments include advances in capsule customization technologies and ongoing expansion of its research capabilities in hollow capsule formulations. The company remains committed to maintaining GMP-compliant production standards and leading the industry in high-quality capsule manufacturing. Anhui Huangshan Capsule is listed on the Shenzhen Stock Exchange (Ticker: 002817.SZ) and continues to enhance its strategic market position through technological innovation and partnerships in pharmaceutical capsule development. Its business operations span manufacturing facilities located in Anhui province, with a customer base comprising pharmaceutical enterprises globally. The company has maintained steady growth through increased production capacity and new product launches focused on specialized capsule types such as enteric-coated variants, reinforcing its role as a leading domestic and influential global player in capsule production and development.